Results of Voting at AGM
February 22 2008 - 3:37AM
UK Regulatory
RNS Number:5380O
Arana Therapeutics Limited
22 February 2008
FOR IMMEDIATE RELEASE 22 FEBRUARY 2007
Arana Therapeutics Limited
Results of Voting @ Annual General Meeting
Held on Thursday 14 February 2008
Arana Therapeutics Limited, (AIM: AAHx ASX: AAH) (the "Company"), the Australian
biopharmaceutical company that uses superior technology to develop next
generation drugs that will improve the lives of patients with inflammatory
diseases and cancer announces the details of the resolutions and the proxies
received in respect of each resolution set out in the proxy summary with respect
to the Company's Annual General Meeting held on 14 February 2008. The following
resolutions were presented and voted on:
Resolution 2 (a): To elect as a Director: Dr Lincoln Chee
That, for all purposes, Dr Lincoln Chee, a Director appointed to the Board since
the last annual general meeting and retiring in accordance with clause 6.3(i) of
the Company's Constitution, being eligible, be elected as a Director.
Total number of proxy votes exercisable by all proxies validly appointed
(excluding abstain) - 56,259,633
Votes where the proxy is directed to vote "for" the 53,400,812
resolution
Votes where the proxy is directed to vote "against" the 1,249,973
resolution
Votes where the proxy is directed to abstain on the 273,617
resolution
Votes where the proxy may exercise a discretion how to vote 1,608,848
Total proxy votes (including abstain) 56,533,250
Carried on a show of hands as an ordinary resolution.
Resolution 2 (b): To elect as a Director: Mr Chris Harris
That, for all purposes, Mr Chris Harris, a Director appointed to the Board since
the last annual general meeting and retiring in accordance with clause 6.3(i) of
the Company's Constitution, being eligible, be elected as a Director.
Total number of proxy votes exercisable by all proxies validly appointed
(excluding abstain) - 56,257,633
Votes where the proxy is directed to vote "for" the 53,631,781
resolution
Votes where the proxy is directed to vote "against" the 1,007,004
resolution
Votes where the proxy is directed to abstain on the 275,617
resolution
Votes where the proxy may exercise a discretion how to vote 1,618,848
Total proxy votes (including abstain) 56,533,250
Carried on a show of hands as an ordinary resolution.
Resolution 2 (c): To elect as a Director: Dr George Jessup
That, for all purposes, Dr George Jessup, a Director appointed to the Board
since the last annual general meeting and retiring in accordance with clause 6.3
(i) of the Company's Constitution, being eligible, be elected as a Director.
Total number of proxy votes exercisable by all proxies validly appointed
(excluding abstain) - 56,259,733
Votes where the proxy is directed to vote "for" the 53,713,764
resolution
Votes where the proxy is directed to vote "against" the 917,021
resolution
Votes where the proxy is directed to abstain on the 273,617
resolution
Votes where the proxy may exercise a discretion how to vote 1,628,848
Total proxy votes (including abstain) 56,533,250
Carried on a show of hands as an ordinary resolution.
Resolution 2 (d): To elect as a Director: Mr Robin Beaumont
That, for all purposes, Mr Robin Beaumont, a Director appointed to the Board
since the last annual general meeting and retiring in accordance with clause 6.3
(i) of the Company's Constitution, being eligible, be elected as a Director.
Total number of proxy votes exercisable by all proxies validly appointed
(excluding abstain) - 56,257,173
Votes where the proxy is directed to vote "for" the 53,642,786
resolution
Votes where the proxy is directed to vote "against" the 991,539
resolution
Votes where the proxy is directed to abstain on the 276,077
resolution
Votes where the proxy may exercise a discretion how to vote 1,622,848
Total proxy votes (including abstain) 56,533,250
Carried on a show of hands as an ordinary resolution.
Resolution 3: Adopt Remuneration Report
That the Remuneration Report for the financial year ended 30 September 2007 as
disclosed in the Directors' Report be adopted.
Total number of proxy votes exercisable by all proxies validly appointed
(excluding abstain) - 56,354,217
Votes where the proxy is directed to vote "for" the 23,642,417
resolution
Votes where the proxy is directed to vote "against" the 31,072,377
resolution
Votes where the proxy is directed to abstain on the 179,033
resolution
Votes where the proxy may exercise a discretion how to vote 1,639,423
Total proxy votes (including abstain) 56,533,250
Not carried on a show of hands as an advisory resolution.
Resolution 4: AIM - Cancellation of admission
That the cancellation of the admission of the Company's Ordinary Shares on the
Alternative Investment Market (AIM), a market regulated by the London Stock
Exchange plc, is hereby approved.
Total number of proxy votes exercisable by all proxies validly appointed
(excluding abstain) - 56,268,455
Votes where the proxy is directed to vote "for" the 54,542,674
resolution
Votes where the proxy is directed to vote "against" the 158,058
resolution
Votes where the proxy is directed to abstain on the 264,795
resolution
Votes where the proxy may exercise a discretion how to vote 1,567,723
Total proxy votes (including abstain) 56,533,250
Carried on a show of hands as a special resolution.
For further information, please contact:
Arana Therapeutics Limited
Dr John Chiplin, Chief Executive Officer +61 (0)2 8061 9900
Niall Henderson, Chief Financial Officer +61 (0)2 8061 9900
Buchanan Communication
Lisa Baderoon/Rebecca Skye Dietrich +44 (0)20 7466 5000
Nomura Code Securities
Charles Walker +44 (0)20 7776 1206
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCFKBKNFBKKPBB
Arana Therap. (LSE:AAHX)
Historical Stock Chart
From May 2024 to Jun 2024
Arana Therap. (LSE:AAHX)
Historical Stock Chart
From Jun 2023 to Jun 2024
